Target intelligence / Profile preview

Transmembrane protein 167A pseudogene 1 (TMEM167AP1)

Target
TMEM167AP1
Molecular classification
Other (pseudogene)
01

Overview

Transmembrane protein 167A pseudogene 1 (TMEM167AP1) is classified as a human pseudogene by genomic databases. Pseudogenes are DNA sequences resembling known genes but harbor mutations or deletions that prevent them from encoding functional proteins. There is no evidence TMEM167AP1 is transcribed or translated into a functional protein, nor is it implicated in known biological processes, disease mechanisms, or therapeutic targeting. Information specific to its sequence, function, or clinical relevance is absent from major gene and protein knowledgebases, supporting its categorization as a nonfunctional genomic element. Major gene reference sources, such as GeneCards, list TMEM167AP1 strictly as a pseudogene: "Transmembrane protein 167A pseudogene 1, including: function, proteins, disorders, pathways, orthologs" but do not offer evidence of function, pathology, or targeting. There is no evidence in available biomedical reviews that TMEM167AP1 encodes a receptor, enzyme, transporter, or other druggable target. The nomenclature and abbreviations are standard for uncharacterized loci; no additional aliases are assigned. Therefore, TMEM167AP1 is not a functional therapeutic target and is best categorized as an uncharacterized pseudogene.

Beyond the preview

Go deeper on Transmembrane protein 167A pseudogene 1 (TMEM167AP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 167A pseudogene 1 (TMEM167AP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call